Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms
Status:
Unknown status
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
Phase 1, non-randomized, open label, noncomparative trial to study the effect of intravitreal
injection of aflibercept on eyes with symptomatic macular edema from retinal artery
macroaneurysms.